Patent · US Active

Ghrelin variant protein

US8088730B2 · kind B2 · utility

1Cited by
3References
13Claims
0Family size

Inventor

Key dates

Filing dateOct 13, 2006
Grant dateJan 3, 2012
Priority date
Expiry dateDec 22, 2028

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S930/12
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention concerns thirteen novel variants of alternative splicing of the obesity and/or diabetes related genes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.